| Immunological and inflammatory profiles in mild and severe cases of COVID-19 JW Song, C Zhang, X Fan, FP Meng, Z Xu, P Xia, WJ Cao, T Yang, XP Dai, ... Nature communications 11 (1), 3410, 2020 | 416 | 2020 |
| Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) C Agrati, A Sacchi, V Bordoni, E Cimini, S Notari, G Grassi, R Casetti, ... Cell Death & Differentiation 27 (11), 3196-3207, 2020 | 245 | 2020 |
| Cutting edge: TGF-β1 and IL-15 induce FOXP3+ γδ regulatory T cells in the presence of antigen stimulation R Casetti, C Agrati, M Wallace, A Sacchi, F Martini, A Martino, A Rinaldi, ... The Journal of Immunology 183 (6), 3574-3577, 2009 | 219 | 2009 |
| Extremely potent human monoclonal antibodies from COVID-19 convalescent patients E Andreano, E Nicastri, I Paciello, P Pileri, N Manganaro, G Piccini, ... Cell 184 (7), 1821-1835. e16, 2021 | 213 | 2021 |
| 2019-novel coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation F Albarello, E Pianura, F Di Stefano, M Cristofaro, A Petrone, L Marchioni, ... International Journal of Infectious Diseases 93, 192-197, 2020 | 211 | 2020 |
| Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases R Carsetti, S Zaffina, E Piano Mortari, S Terreri, F Corrente, C Capponi, ... Frontiers in immunology 11, 610300, 2020 | 202 | 2020 |
| Molecular mechanisms of Ebola virus pathogenesis: focus on cell death L Falasca, C Agrati, N Petrosillo, A Di Caro, MR Capobianchi, G Ippolito, ... Cell Death & Differentiation 22 (8), 1250-1259, 2015 | 202 | 2015 |
| Unique human immune signature of Ebola virus disease in Guinea P Ruibal, L Oestereich, A Lüdtke, B Becker-Ziaja, DM Wozniak, R Kerber, ... Nature 533 (7601), 100-104, 2016 | 186 | 2016 |
| Humoral-and T-cell–specific immune responses to SARS-CoV-2 mRNA vaccination in patients with MS using different disease-modifying therapies C Tortorella, A Aiello, C Gasperini, C Agrati, C Castilletti, S Ruggieri, ... Neurology 98 (5), e541-e554, 2022 | 162 | 2022 |
| Lack of CD27− CD45RA− Vγ9Vδ2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis C Gioia, C Agrati, R Casetti, C Cairo, G Borsellino, L Battistini, G Mancino, ... The Journal of Immunology 168 (3), 1484-1489, 2002 | 135 | 2002 |
| Antiviral reactivities of γδ T cells F Poccia, C Agrati, F Martini, MR Capobianchi, M Wallace, M Malkovsky Microbes and infection 7 (3), 518-528, 2005 | 130 | 2005 |
| In vivo effects of zoledronic acid on peripheral γδ T lymphocytes in early breast cancer patients D Santini, F Martini, ME Fratto, S Galluzzo, B Vincenzi, C Agrati, F Turchi, ... Cancer Immunology, Immunotherapy 58, 31-38, 2009 | 120 | 2009 |
| Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza C Gioia, C Castilletti, M Tempestilli, P Piacentini, L Bordi, R Chiappini, ... Emerging Infectious Diseases 14 (1), 121, 2008 | 119 | 2008 |
| An inflammatory profile correlates with decreased frequency of cytotoxic cells in coronavirus disease 2019 V Bordoni, A Sacchi, E Cimini, S Notari, G Grassi, E Tartaglia, R Casetti, ... Clinical Infectious Diseases 71 (16), 2272-2275, 2020 | 116 | 2020 |
| Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19 M Tempestilli, P Caputi, V Avataneo, S Notari, O Forini, L Scorzolini, ... Journal of Antimicrobial Chemotherapy 75 (10), 2977-2980, 2020 | 115 | 2020 |
| Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome A Sacchi, G Grassi, V Bordoni, P Lorenzini, E Cimini, R Casetti, ... Cell death & disease 11 (10), 921, 2020 | 113 | 2020 |
| Anti–severe acute respiratory syndrome coronavirus immune responses: the role played by Vγ9Vδ2 T cells F Poccia, C Agrati, C Castilletti, L Bordi, C Gioia, D Horejsh, G Ippolito, ... The Journal of infectious diseases 193 (9), 1244-1249, 2006 | 103 | 2006 |
| Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections S Terreri, EP Mortari, MR Vinci, C Russo, C Alteri, C Albano, F Colavita, ... Cell host & microbe 30 (3), 400-408. e4, 2022 | 102 | 2022 |
| T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies V Marasco, C Carniti, A Guidetti, L Farina, M Magni, R Miceli, L Calabretta, ... British journal of haematology 196 (3), 548-558, 2022 | 96 | 2022 |
| Humoral and cellular immune response elicited by mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with human … A Antinori, S Cicalini, S Meschi, V Bordoni, P Lorenzini, A Vergori, ... Clinical Infectious Diseases 75 (1), e552-e563, 2022 | 93 | 2022 |
